Cargando…
Mesenchymal Stem Cells with Granulocyte Colony-Stimulating Factor Reduce Stress Oxidative Factors in Parkinson's Disease
BACKGROUND: Recent studies have shown that BMSCs have a putative ability to promote neurogenesis and produce behavioral and functional improvement. Our previous study demonstrated that co-treatment of G-CSF and BMSCs have beneficial effects on Parkinson's models. The main purpose of this resear...
Autores principales: | Ghahari, Laya, Safari, Manouchehr, Rahimi Jaberi, Khojaste, Jafari, Behnaz, Safari, Katayoun, Madadian, Mahmoodreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute of Iran
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984711/ https://www.ncbi.nlm.nih.gov/pubmed/31677610 http://dx.doi.org/10.29252/ibj.24.2.89 |
Ejemplares similares
-
Effect of Combination Therapy Using Hypothermia and Granulocyte Colony-Stimulating Factor in a Rat Transient Middle Cerebral Artery Occlusion Model
por: Ghahari, Laya, et al.
Publicado: (2014) -
Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson Disease
por: Rahimi Jaberi, Khojasteh, et al.
Publicado: (2022) -
G-CSF for mobilizing transplanted bone marrow stem cells in rat model of Parkinson’s disease
por: Safari, Manouchehr, et al.
Publicado: (2016) -
Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson’s disease
por: Zarbakhsh, Sam, et al.
Publicado: (2019) -
Mesenchymal stem cells that located in the electromagnetic fields improves rat model of Parkinson’s disease
por: Jadidi, Majid, et al.
Publicado: (2016)